Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations

Contact us

• Submission enquiries: editorial@genomemedicine.com
• General enquiries: info@biomedcentral.com